IL1R1

Across TCGA pan-cancer cohorts, IL1R1 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated IL1R1 data layer compared with 22 for mass-spec protein and 7 for mutation status.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher IL1R1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated IL1R1 expression acts as an unfavorable survival marker, although some lineages such as LUAD show a favorable association.

LSCC and LUAD are the cancer types where IL1R1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LSCC	OS	Median	II,III,IV	0.534	0.893	.001	14	view →
LUAD	DFS	Median	All	0.867	0.543	.048	1	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

IL1R1–LSCC (OS)

Open the LSCC breakdown →